Wu et al. reported increased expression levels of Beclin1, LC3, and mTOR in colorectal cancer cells, which the increased LC3 expression levels exhibited a positive correlation with increased Beclin1 and cell differentiation and negative correlation with mTOR expression levels. This evidence concerns the gene MAP1LC3A and colorectal cancer.